Nostrum Laboratories is recalling 60,608 bottles of Sucralfate (sucralfate) Tablets, USP 1 gram. The recall includes both 100-count and 500-count bottles. This action was taken because the company filed for bankruptcy and can no longer monitor its quality control programs, meaning they cannot guarantee the medication meets standards for identity, strength, quality, and purity.
Because the manufacturer cannot assure the quality of the drug, the products are considered adulterated. This could lead to patients receiving medication that is ineffective or does not contain the correct amount of active ingredient, potentially failing to treat the underlying gastrointestinal conditions for which it was prescribed.
You have 2 options:
Rx Only. Recalling firm filed for Chapter 11 in September 2024.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.